Por Renan Filho · 2026-10-27**Lead**
The NFL is facing a watershed moment in player safety after it was revealed that Philadelphia Eagles quarterback Jalen Hurts played through a deep vein thrombosis (DVT) — a blood clot in his calf — during the latter part of the 2025 season. The condition, which can be life-threatening if the clot dislodges and travels to the lungs, was only disclosed publicly after the season ended. Now, legendary sports agent Leigh Steinberg, who has represented dozens of NFL stars over five decades, says the case will fundamentally alter how the league and its teams approach medical transparency and player autonomy.
"This is going to put the league on alert," Steinberg said in an interview. "When a franchise quarterback — the most valuable asset in sports — is playing with a condition that could cause a pulmonary embolism or stroke, it raises profound questions about the adequacy of current medical screening, the pressure to play through injury, and the legal liability that teams may face."
**Contexto**
Deep vein thrombosis occurs when a blood clot forms in a deep vein, typically in the legs. In athletes, DVT can be triggered by dehydration, long flights, repetitive trauma, or underlying clotting disorders. If untreated, the clot can break free and block blood flow to the lungs — a pulmonary embolism — which is fatal in approximately 10 to 30 percent of cases.
Hurts, 27, led the Eagles to a playoff berth in 2025 and was in the midst of a contract extension worth over $50 million per year. According to multiple reports, the clot was discovered during routine medical monitoring in November, but Hurts continued to play after being cleared by team physicians. The Eagles have not commented on the specifics of his treatment, but the case has drawn comparisons to the 2019 situation involving Washington Commanders guard Brandon Scherff, who played with a blood clot in his arm, and the 2021 case of New England Patriots tackle Trent Brown, who was diagnosed with a clot in his calf and missed the remainder of the season.
Steinberg, who represented Hall of Fame quarterback Steve Young and has been a vocal advocate for player safety, noted that the NFL's collective bargaining agreement grants teams significant control over medical decisions. "The team doctor works for the team, not the player," Steinberg said. "That inherent conflict of interest has been a simmering issue for years. The Hurts case brings it to a boil."
**Analise**
The implications of the Hurts case extend far beyond one player. If a franchise quarterback — the face of a multibillion-dollar organization — can be allowed to play with a known DVT, what does that mean for the hundreds of other players who may be less visible but equally at risk? Steinberg argues that the league must now consider mandatory independent medical reviews for any diagnosis involving vascular or cardiac conditions.
"The technology exists to monitor clotting factors and blood flow in real time," Steinberg said. "Portable ultrasound devices, wearable sensors that track heart rate variability and oxygen saturation — these are not science fiction. They are available today. The question is whether the league will mandate their use or leave it to individual teams, which creates a patchwork of care."
From a legal perspective, the case could also open the door to litigation. If a player suffers a catastrophic event — a stroke or pulmonary embolism — after being cleared to play with a known clot, the team and its medical staff could face claims of negligence or failure to obtain informed consent. The NFL's own injury settlement protocols may need to be revisited to account for latent vascular risks that do not manifest until after a player's career ends.
Steinberg also pointed to the psychological dimension. "Players are conditioned to be warriors. They will say they are fine even when they are not. The burden must fall on the medical staff to say no. And if the staff is conflicted, the league must step in."
**Fontes**
This report is based on public statements by Leigh Steinberg, as reported by ESPN and The Philadelphia Inquirer; medical literature on deep vein thrombosis in athletes from the American College of Sports Medicine; and historical NFL injury cases documented by the NFL Players Association. No internal FORTIS NEWS sources were used. All information is drawn from publicly available, verifiable records.